New insights into the functions of Cox-2 in skin and esophageal malignancies
Cancer: Inflammatory enzyme linked to skin and esophageal tumors Drugs that block a pro-inflammatory enzyme implicated in cancer initiation and progression could help suppress the development of skin and esophageal cancers that arise from abnormal squamous cells (skin cells and cells lining the resp...
Main Authors: | Hyeongsun Moon, Andrew C. White, Alexander D. Borowsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-04-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-020-0412-2 |
Similar Items
-
COX-2 Silencing in Canine Malignant Melanoma Inhibits Malignant Behaviour
by: Tatiany L. Silveira, et al.
Published: (2021-08-01) -
COX-2 strengthens the effects of acid and bile salts on human esophageal cells and Barrett esophageal cells
by: Hongfang, W., et al.
Published: (2022) -
The Malignant Phenotype of Breast Cancer Cells Is Reduced by COX-2 Silencing
by: Ioannis Stasinopoulos, et al.
Published: (2008-11-01) -
Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2.
by: Haitao Li, et al.
Published: (2013-01-01) -
New horizons in skin malignancies treatment
by: S V Gamaunov
Published: (2014-06-01)